Fourth coronavirus vaccine could be approved in UK as it clears major hurdle

A woman passes a Government coronavirus advert in a bus shelter in central London (Dominic Lipinski/PA)

A fourth Covid-19 vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing coronavirus.

The UK has secured 60 million doses of the Novavax jab – to be produced on Teesside – which is believed to offer protection against the new UK and South African variants.